Aurobindo Pharma & Covaxx to develop COVID-19 vaccine for India, Unicef
New Delhi; Aurobindo Pharma Limited and Covaxx, a US-based company, have entered into an Exclusive License Agreement to develop, commercialize and manufacture UB-612, the first Multitope Peptide-based vaccine to fight Covid-19, for India and the UN Children's Fund (Unicef) agency. COVAXX is currently conducting a...











































